Vol. 273, Issue 4, H1977-H1983, October 1997
Expression of adenine nucleotide translocator parallels
maturation of respiratory control in heart in vivo
Michael A.
Portman,
Yun
Xiao,
Ying
Song, and
Xue-Han
Ning
Division of Cardiology, Department of Pediatrics, University of
Washington School of Medicine and Children's Hospital and Medical
Center, Seattle, Washington 98195-6320
 |
ABSTRACT |
Changes in the
relationship between myocardial high-energy phosphates and oxygen
consumption in vivo occur during development, implying that the mode of
respiratory control undergoes maturation. We hypothesized that these
maturational changes in sheep heart are paralleled by alterations in
the adenine nucleotide translocator (ANT), which are in turn related to
changes in the expression of this gene. Increases in myocardial oxygen
consumption (M
O2) were
induced by epinephrine infusion in newborn (0-32 h,
n = 6) and mature sheep (30-32
days, n = 6), and high-energy
phosphates were monitored with 31P
nuclear magnetic resonance. Western blot analyses for the
ANT1 and the
-subunit of
F1-adenosinetriphosphatase
(ATPase) were performed in these hearts and additional
(n = 9 total per group) as well as in
fetal hearts (130-132 days of gestation,
n = 5). Northern blot analyses were
performed to assess for changes in steady-state RNA transcripts for
these two genes. Kinetic analyses for the
31P spectra data revealed that the
ADP-M
O2 relationship for
the newborns conformed to a Michaelis-Menten model but that the mature data did not conform to first- or second-order kinetic control of
respiration through ANT. Maturation from fetal to mature was accompanied by a 2.5-fold increase in ANT protein (by Western blot),
with no detectable change in
-F1-ATPase. Northern blot data
show that steady-state mRNA levels for ANT and
-F1-ATPase increased
~2.5-fold from fetal to mature. These data indicate that
1) respiratory control pattern in
the newborn is consistent with a kinetic type regulation through ANT,
2) maturational decreases in control
through ANT are paralleled by specific increases in ANT content, and
3) regulation of these changes in
ANT may be related to increases in steady-state transcript levels for
its gene.
myocardial oxygen consumption; mitochondria; sheep; adenosine
5'-triphosphate; adenosinetriphosphatase; oxidative
phosphorylation
 |
INTRODUCTION |
MITOCHONDRIAL ATP synthesis is tightly coupled to
cytosolic ATP utilization in both developing myocardium and the mature
heart (18, 24). However, the mode of signal transduction between these
two processes appears to change as a function of development. Previous
work performed in vitro has generally implied that mitochondrial oxidative phosphorylation responds to increases in cytosolic ADP in a
hyperbolic relation emulating a Michaelis-Menten mechanism (15, 20).
Studies in mature myocardium in vivo, however, have demonstrated that
substantial increases in oxygen consumption are accompanied by minimal
change in ADP (18, 24). Thus signal transduction in mature myocardium
does not approximate first-order kinetics proposed from isolated
mitochondrial studies. In contrast, in newborn myocardium, the relation
of oxidative phosphorylation and ADP does appear to follow a simple
Michaelis-Menten pattern (23). Alternatively, such increases in ADP
during elevated rates of myocardial work in the newborn may instead
reflect a decrease in sensitivity to ADP, and more elevated levels are
required to drive respiration. Recently, second-order or greater
kinetics have been proposed for respiratory control, implying that
mature myocardium is exquisitely sensitive to ADP (17). This signal transduction pattern is consistent with a substantial level of control
through the adenine nucleotide translocator (ANT), the protein carrier
responsible for mitochondrial membrane ADP/ATP exchange. Accordingly,
alterations in ADP sensitivity could be due to changes in the apparent
number of cooperative ANT binding sites.
Recent work has shown that newborn tissues including myocardium are
deficient in ANT sites compared with mature tissues (28). In this
study, we have proposed that maturational changes in the relation
between ADP and oxidative phosphorylation in vivo are also related to
mitochondrial biogenesis with changes in ANT. Furthermore, we postulate
that maturation is accompanied by changes in expression of the gene
controlling this protein. We have taken a novel approach of study, by
which these relations studied in a physiological model in vivo were
compared with corresponding protein expression assessed by Western
blot, and gene expression assessed through steady-state mRNA levels
demonstrated on Northern blots. The model of study is the sheep, in
which high-energy phosphate metabolism has been previously outlined
during both aerobic and anaerobic conditions in vivo (24, 26).
 |
METHODS |
Animal preparation.
Animals used in this study were handled in accordance with
institutional and National Institutes of Health animal care and use
guidelines. Newborn sheep were 0-32 h old, and mature sheep were
30-32 days old. Sheep were sedated with an intramuscular injection
of 10 mg/kg ketamine and 0.2-0.4 mg/kg xylazine, intubated, and
then ventilated (C-900 pediatric ventilator, Siemens, Schaumberg, IL)
with room air and oxygen followed by an intravenous dose of
-chloralose (40 mg/kg). Femoral arterial cannulation was performed for monitoring systemic blood pressure and sampling blood. Arterial pH
was maintained between 7.35 and 7.45 by adjustment of ventilatory tidal
volume and correction of metabolic acidosis with sodium bicarbonate
infusion. After median sternotomy, a coronary sinus-to-superior vena
caval shunt was placed as described previously for measurement of
coronary sinus flow and myocardial oxygen consumption (24). Platinum-tipped pacing electrodes were sutured to the right atrial appendage. A 2-cm-diameter nuclear magnetic resonance (NMR) surface coil was sutured to the left ventricular apex. The thoracotomy opening
was sealed with plastic wrap to prevent water loss. The sheep, wrapped
in a water circulating heating blanket that maintained body temperature
at ~38°C, was placed in the 6-cm clear bore of the 4.7-T chemical
shift imaging system. The surface coil was positioned at the magnetic
center of the system. Blood pressure and coronary sinus flow were
recorded on hard copy and to a Macintosh laptop computer equipped with
Biotech data-acquisition software.
NMR measurements.
After the sheep were transferred into the magnet, the surface coil was
tuned to 81 MHz and matched to 50
. NMR data were collected with a
General Electric (Fremont, CA) spectrometer using resident software.
Shimming on the 1H free induction
decay at 200 MHz and acquisition of
31P spectra were performed as
previously described, employing cardiac gating (24). The interpulse
delay was ~2 s, and the pulse width optimized for the phosphocreatine
(PCr) signal, 20-40 µs. All spectra were obtained with a simple
one-pulse sequence. Data were acquired with a 5,000-Hz sweep width and
2,048 data points. Sixteen spectra were stored in data-acquisition
blocks, and four blocks were averaged for analyses. All spectra were
analyzed using a least-squares fit program as well as integration.
Fully relaxed spectra were obtained before data acquisition and used
for analyses and correction for saturation. Intracellular pH was
determined from the chemical shift difference
Pi vs. PCr as previously described (24).
Protocol.
After stabilization, baseline data were obtained over 8 min. This was
followed by epinephrine infusion beginning at 1 µg · kg
1 · min
1
and titrated upward until a doubling of the mean rate-pressure product
was obtained. Data were then acquired for 8 min, and the infusion was
increased until a tripling of the mean rate-pressure product was
obtained. Epinephrine was decreased and discontinued after 10 min, and
8 min of baseline data were obtained. Hemodynamic data were recorded
throughout, and blood sampling was performed at the 4th min. After the
protocol was completed, the heart was rapidly excised, and tissue was
removed for Northern and Western blotting studies. Additional tissue
was obtained from two newborns, which did not undergo the protocol, and
from five fetal lambs (130-132 days of gestation) obtained from
cesarean section.
RNA isolation.
After excess fat and adhering connective tissues were removed, the left
ventricular wall was quickly blotted dry, frozen in liquid nitrogen,
and stored at
80°C. An aliquot (200 mg) of the frozen tissue
was pulverized and homogenized, and total RNA was extracted with a RNA
isolation kit (Ambion, Austin, TX). RNA samples were tested by
ultraviolet absorption ratio
A260/A280
for purity and concentration. Values for
A260/A280
were >1.8 for all RNA extraction. The quality and concentration of
the RNA samples were further confirmed by electrophoresis on denatured
1% agarose gels.
Northern blot analysis.
RNA (15 µg) was denatured, electrophoresed into a 1% formaldehyde
agarose gel, transferred to a nitrocellulose transfer membrane (Micron
Separations, Westboro, MA), and cross-linked to the membrane with
short-wave ultraviolet light. The prehybridizing and hybridizing solutions contained 50% formamide, 1× Denhardt's solution,
6× saline-sodium phosphate-EDTA, and 1% sodium dodecyl sulfate
(SDS). cDNA probes were labeled with
[32P]dCTP by random
primer extension (Prime-It II, Stratagene, La Jolla, CA) and added to
the hybridizing solution. Hybridization was performed at 42°C for
18 h. The blots were then washed several times with a final wash in
0.1× standard sodium citrate (SSC) and 0.1% SDS at 65°C. The
relative content of mRNAs was evaluated by scanning densitometry using
a PhosphorImager model 400S and ImageQuant quantitation software
(Molecular Dynamics, Sunnyvalve, CA).
ANT1 and
-F1-adenosinetriphosphatase
(ATPase) mRNA loading was normalized to 28S ribosomal RNA band.
ANT1 mRNA levels were detected
using a 1.4-kb insert cDNA cloned from the human skeletal muscle
[American Type Culture Collection (ATCC), Rockville, MD].
-F1-ATPase mRNA levels were
detected using a 1.8-kb insert cDNA cloned from human HeLa cell line
(ATCC). To compare different mRNA levels in the same myocardial sample,
aliquots of 15 µg of total RNA from the myocardium were analyzed by
means of reprobing the membrane with 28S,
ANT1, and
-F1-ATPase cDNA probes.
Western blot analysis.
Frozen tissue samples were homogenized in boiling 2% SDS extract
solution, and the homogenates were centrifuged at 2,000 g. Aliquots of the resulting
supernatants were fractionated in SDS, 12.5% polyacrylamide gels,
transferred to polyvinylidene difluoride membranes (Millipore), and
Western blotted with antisera developed in rabbit to purified rat liver
mitochondrial
-F1-ATPase (22) or rabbit antisera to rat heart adenine nucleotide translocase (5). The
immunoreactive protein was visualized with goat anti-rabbit immunoglobulin G-peroxidase conjugate. All blots were developed with
the enhanced chemiluminescence system (Amersham). Intensity of the ANT
or
-F1-ATPase bands was
performed with laser densitometric scanning. For standardization
purposes, the same amount of protein was run in parallel lanes on an
SDS gel. Densitometric scanning revealed no differences in the amount
of protein loaded per lane. Quantitation was performed with scanning
densitometry.
 |
RESULTS |
High-energy phosphates and oxygen consumption.
Metabolic data for the mature and newborn groups are summarized in
Tables 1 and
2, respectively. The newborns studied in these experiments were a few days younger than those investigated in
our previous experiments (24, 25). Pressure-rate product (mean blood
pressure × heart rate) is also reported in Tables 1 and 2.
Similar baseline oxygen consumption rates were present in the two
groups. The range and peak oxygen consumption rates induced by
epinephrine infusion were also similar. As noted in previous studies
(24, 25) the mature sheep do not show any change in PCr/ATP during
these twofold or slightly greater increases in oxygen consumption.
Although this oxygen consumption increase is fairly mild relative to
the range in unsedated lambs (6), it is nevertheless accompanied by
substantial and significant decreases in PCr/ATP in newborn lambs
(P < 0.001 vs. baseline and mature
sheep values). Cytosolic ADP concentration calculation in this sheep
model has been described in detail previously (24, 25). These values
are derived from previous determinations of cytosolic ATP and creatine,
which are applied using the creatine kinase reaction and the
equilibrium constant published by Lawson and Veech (21). Ingwall et al.
(12) have shown that developmental changes in cytosolic ATP and
creatine pools do not occur after birth in sheep. PCr/ATP is slightly
lower and calculated ADP is slightly higher at baseline in the newborn
sheep. This represents a difference from previous studies (24, 25),
which demonstrated that a cohort of lambs with age a few days older
showed no difference from a mature group. Unlike the mature sheep,
these newborns do substantially increase ADP during increases in oxygen
consumption. Individual ADP vs. oxygen consumption data are plotted in
Fig. 1 for the two groups. Representative
spectra from a newborn lamb experiment with difference spectra are
plotted in Fig. 2. These data show that
corresponding increases in Pi
occur during the decreases in PCr, whereas ATP remains stable. Although
there is individual variability, intracellular pH does not change
significantly during oxygen consumption increases in either group.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
Myocardial oxygen consumption vs. ADP plotted for individual
experiments in mature (A) and
newborn (B) sheep. Each symbol
represents a different sheep; n = 6.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
Representative spectra from a newborn lamb experiment are shown.
A, baseline;
B, obtained during a 2-fold increase
in myocardial oxygen consumption; C,
difference spectra (A B). Corresponding increase in
Pi occurs during phosphocreatine
(PCr) decrease. In this particular experiment, there is a slight
downfield shift to Pi peak,
indicating a drop in intracellular pH
(pHi). However,
pHi did not change significantly
in entire experimental group. PPM, parts per million.
|
|
Steady-state mRNA levels.
Semiquantitative analyses of steady-state mRNA levels for ANT and
-F1-ATPase were performed with
Northern blotting for three groups: fetal
(n = 5), newborn
(n = 9), and mature
(n = 9). A representative Northern
blot is demonstrated in Fig. 3. Figure 3
(left) shows bands for 28S ribosomal
RNA as well as the bands for ANT1;
Fig. 3 (right) shows reprobing for
-F1-ATPase in the same
membrane. In many species ANT1
gene expression in heart and skeletal muscle far exceeds that of the
other two ANT genes, ANT2 and
ANT3. Because these latter genes
are weakly expressed in heart, only steady-state transcript levels for
ANT1 were assessed. Similar to
bovine heart, two ANT1 transcripts
were observed to produce dual bands at 1.4 and 1.2 kb in sheep heart.
Stepien et al. (30) have attributed these two bands to different length
3'-nontranslated sequences generated by the bovine genes' two
polyadenylation sites. Relative intensities for each mRNA in the
separate age groups are shown in Fig. 4.
These data show that, for both
ANT1 and
-F1-ATPase, there are
statistical differences for steady-state mRNA levels between fetal and
mature groups. There is an ~2.5-fold increase in steady-state levels
of mRNAs for both of these genes during the transition from fetal to
the mature age (30 days in this model). These data thus indicate that
there is a coordinated increase in these steady-state transcript levels
during this maturational period.

View larger version (92K):
[in this window]
[in a new window]
|
Fig. 3.
Representative Northern blot loaded with ventricular myocardium and
specific probes as noted. Same blot was reprobed for
-F1-ATPase. Two
adenine nucleotide translocator
(ANT1) bands appear at 1.4 and
1.2 kb. This blot emphasizes increases in
ANT1 and
-F1-ATPase RNA with maturation.
F, fetal; N, newborn (0-32 h); M, mature (30-32 days).
|
|

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 4.
Relative densitometric intensities for
ANT1 and
-F1-ATPase are shown for each
age groups. Intensities are normalized to 28S band intensity.
Significant increase in intensities occur during maturation from fetal
to mature.
|
|
Protein levels.
Protein levels for ANT and
-F1-ATPase in heart were
assessed semiquantitatively by Western blotting. A representative
Western blot is shown in Fig. 5. Relative
normalized densitometric intensities are shown in Fig.
6. These data demonstrate a greater than
twofold increase in ANT1 during
the maturational transition between the fetal and mature heart. The
data imply that increases in this protein's levels occur after the 1st
or 2nd day of life. In contrast, there appears to be no change in
-F1-ATPase after 130 days of gestation in the sheep heart.

View larger version (83K):
[in this window]
[in a new window]
|
Fig. 5.
Representative Western blots assess relative amounts of mitochondrial
proteins (ANT1 and
-F1-ATPase) in left ventricular
myocardium during different developmental states (F, N, and M).
Unmarked lane is reference with migration of molecular mass markers as
noted. A: total protein is similar in
all lanes. B: bands for
ANT1 and
-F1-ATPase after
immunoprecipitation with specific anitibodies. Substantial increase in
ANT1 protein but not in
-F1-ATPase occurs with
maturation.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 6.
Normalized densitometric intensities for protein bands from Western
blots are shown. These data imply that a greater than twofold increase
in ANT1 protein levels occurs
during maturation from fetal to mature. However, no detectable increase
in -F1-ATPase protein occurs
during same period.
|
|
 |
DISCUSSION |
Kinetics.
The data obtained in these studies are consistent with the hypothesis
that ANT participates in regulation of myocardial respiration in the
newborn. Possibly, limitations in translocator function are responsible
at least in part for observed maturational changes in the relation
between oxidative phosphorylation and ADP. The nature of limitations in
the translocator is unclear. Investigators have previously assumed that
respiratory regulation is dependent on ADP availability at the
mitochondrial membrane (15, 16, 20). This concept is consistent with
regulation through the translocator, which should follow simple
Michaelis-Menten kinetics. However, lack of predicted change in ADP
during increases in myocardial oxygen consumption in mature myocardium
in vivo has led to conclusions that respiratory control must occur
through alternative mechanisms (2, 8, 9), including control through
changes in reducing equivalent supply to the respiratory chain as well
as through modulation of mitochondrial
Ca2+ concentration (2, 8, 9).
Jeneson et al. (17) stimulated renewed interest in the translocator by
fitting data obtained from several published diverse experimental
preparations, including canine myocardium in vivo (18), to a model
employing sensitivity amplification as described by Koshland (19). This
ultrasensitivity model demonstrates substantially greater change in
reaction velocity (oxidative phosphorylation) over a much narrower
range in relative substrate (ADP) concentration than defined by the
hyperbolic relationship of Michaelis-Menten kinetics. Increased
sensitivity can be due to allosteric type enzyme activation and is
consistent with cooperative activation of ANT. Corroboration of the
ultrasensitivity model in vivo usually requires data from a wide range
of respiratory rates. The model as published used canine data obtained
during increases in ADP induced by phenylephrine infusion and possibly due to relative ischemia but not to increases in myocardial oxygen consumption rate. To evaluate sigmoid saturation kinetics over a
relatively narrow range of respiratory rates, a graphic representation of the Hill equation can be employed (27). In the form of a straight
line, the Hill equation for the relation between ADP and
respiratory rate can be adapted as log
vi/(Vmax
vi) = nlog [S]
log
k', where
vi is the
myocardial oxygen consumption rate, Vmax is the
maximal oxidative phosphorylation rate (taken as 20 µmol · g
1 · min
1
in sheep; Ref. 6), [S] is ADP concentration, and
k' is a complex constant. The
equation states that when the substrate (ADP) is low compared with
k', the reaction velocity
increases as the nth power of the
substrate concentration. A plot of log ADP concentration vs. log
vi/(Vmax
vi)
yields a straight line where the slope equals
n; n
is an empirical parameter whose value depends on the number of
cooperative binding sites. When n = 1, the binding sites act independently of one another; when
n > 1, the sites are
cooperative; and when n < 1, the
sites are said to exhibit negative cooperativity. The data in this
format for the newborn and mature sheep heart experiments are plotted
in Fig. 7. Because there is no significant change in ADP with increases in oxygen consumption in the mature heart,
the derived line is near vertical and the data within this limited
range of respiration do not conform to this model. This would imply
that neither ADP nor the translocator plays a role in regulation of
myocardial respiration in the normal mature heart even if second-order
or greater kinetics are considered. Within the error of the data, the
slope obtained from newborn lambs is consistent with Michaelis-Menten
kinetics (n = 1.0). This
implies that altered cooperativity does not explain the maturational
differences in the relation between ADP and myocardial oxygen
consumption.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 7.
An analysis using Hill equation is shown for mature
(A) and newborn
(B) sheep (see text for details).
These data for mature hearts emphasize lack of change in ADP that
occurs with increases in oxidative phosphorylation. Coefficient for
newborn data (1.0) is consistent with that predicted for
Michaelis-Menten or 1st-order kinetics.
vi, Myocardial
O2 consumption rate;
Vmax, maximal
oxidative phosphorylation rate.
|
|
Adenine nucleotide translocase protein content.
These differences may be due to other factors related to ANT. Changes
in ANT activity or protein content in the mitochondrial membrane might
be responsible for the observed maturational changes in vivo. Previous
work in isolated mitochondria does support the hypothesis that
respiratory control through the translocator decreases with maturation
(28, 29, 32). Although not a specific focus of their study, Wells et
al. (32) demonstrated in isolated sheep mitochondrial preparations that
decoupling of oxidative phosphorylation through DNP produces near
twofold increases in state III respiratory rates in fetal and newborn
mitochondria, with no comparable change occurring in adult
mitochondria. This implies that respiration in fetal and newborn
mitochondria can be limited or regulated at the phosphorylation level,
which consists of two membrane components: mitochondrial ATPase and
ANT. More recently, Shonfeld et al. (29) titrated isolated rat heart
mitochondria from different developmental states with the specific
adenine nucleotide translocase inhibitor, carboxyatractyloside, during
state III respiration. Flux control coefficients estimated
from the titration curves suggest that ANT exerts substantial control
over respiration in the newborn rat heart mitochondria at state III,
which declines progressively to near zero with age. Similar control
patterns were demonstrated by the
F1/F0-ATP
synthase (28). The changes in control through the translocator
corresponded to ANT activity as well as protein content assessed by
Western blot techniques, although age-dependent increases in the
matrix-exchangeable adenylate pool also participate. Similarly, the
present data show that maturational changes in cellular ANT protein
content parallel alterations in the relationship of cytosolic ADP and
respiration in sheep heart in vivo. The current data also indicate that
the F1-ATPase component of the
F1/F0-ATPase reaches adult levels at the fetal stage, thus suggesting that content
of this protein does not influence maturational change in respiratory
control in the sheep heart after birth. The Western blot data with
regard to this particular protein correspond to previous studies which
have shown that no changes in the ATPase activity occur after 136 days
gestation in sheep (32). The lack of change in
-F1-ATPase protein also
demonstrates that the maturational increase in
ANT1 protein is not just part of a
generalized mitochondrial protein increase. Thus the present data
obtained in vivo as well as previous studies in vitro support the
hypothesis that ANT exerts control over myocardial respiration, which
diminishes with age.
Regulation of the expression of the mammalian nuclear-encoded
mitochondrial proteins, ANT1 and
the F1-ATPase, has been described principally in liver (1, 7, 14). Coordinate expression of the genes
controlling the two proteins is well established (4, 30). The Northern
blot data from our experiments, which show a coordinate increase in
steady-state levels of mRNAs for these two proteins in the mature sheep
heart, are consistent with these previous studies. Specific regulation
of the
-subunit of the mitochondrial
F1-ATPase, which has been used as
a reporter protein of nuclear gene activity and as a marker of
mitochondrial biogenesis, occurs both at the transcriptional and
posttranscriptional levels in liver (13, 14, 22). Uncoordinated changes
in RNA and protein levels for the liver
-F1-ATPase occur during
maturation, which may be secondary to tissue-specific activation of
translational factors (14). Izquierdo et al. (14) have shown that
transcript and protein levels for
-F1-ATPase are markedly
elevated in heart relative to other tissues, a finding implying that
regulation is principally exerted at the translational level. It is
thus conceivable that altered translational efficiency may be
responsible for the disparity between maturational changes in
steady-state RNA levels and protein levels for this particular subunit
in heart. In contrast, there appears to be a coordinate increase in the mRNA and protein accumulation of
ANT1 in heart. As stated above, this protein accumulation occurs in parallel with changes in
respiratory control pattern. This implies that maturation of myocardial
respiratory control is induced in part at the transcriptional level,
whether related to stability of RNA or new trancriptional products, as well as at the translational level. Control of transcription
and/or translation of ANT in vitro has been demonstrated to
occur through regulatory factors such as thyroid hormone and oxygen (4,
10, 11, 31), which do change substantially after birth (3).
In summary, these experiments show that regulation of myocardial
respiration changes as a function of development in the sheep heart.
Changes in the adenine nucleotide translocase protein content parallel
maturation of respiratory control. Furthermore, specific increases in
steady-state mRNA levels for this protein are associated with both the
respiratory control changes and accumulation of the protein. This
implies that maturation of myocardial respiratory control may be
stimulated at least in part at the level of transcription.
 |
ACKNOWLEDGEMENTS |
This work was funded by National Heart, Lung, and Blood Institute
Grant HL-47805. Drs. J. M. Cuezva and C. J. Gir'on kindly provided
antibodies for performance of the Western blots in these studies.
 |
FOOTNOTES |
Address for reprint requests: M. A. Portman, Pediatrics, University of
Washington, Box 356320, Seattle, WA 98195-6320.
Received 27 February 1997; accepted in final form 16 June 1997.
 |
REFERENCES |
1.
Aprille, J. R.,
and
G. K. Asimakis.
Postnatal development of rat liver mitochondria: state 3 respiration, adenine nucleotide translocase activity, and the net accumulation of adenine nucleotides.
Arch. Biochem. Biophys.
201:
564-575,
1980[Medline].
2.
Balaban, R. S.,
and
F. W. Heineman.
Control of mitochondrial respiration in the heart in vivo.
Mol. Cell. Biochem.
89:
191-197,
1989[Medline].
3.
Breall, J. A.,
A. M. Rudolph,
and
M. A. Heyman.
Role of thyroid hormone in postnatal circulatory and metabolic adjustments.
J. Clin. Invest.
73:
1418-1424,
1984.
4.
Chung, A. B.,
G. Stepien,
Y. Haraguchi,
K. Li,
and
D. C. Wallace.
Transcriptional control of nuclear genes for the mitochondrial muscle ADP/ATP translocator and the ATP synthase beta subunit. Multiple factors interact with the OXBOX/REBOX promoter sequences.
J. Biol. Chem.
267:
21154-21161,
1992[Abstract/Free Full Text].
5.
Gir'on, C.-J.,
C. W. Zwizinski,
and
H. H. Schmid.
Peroxidative damage to cardiac mitochondria. II. Immunological analysis of modified adenine nucleotide translocase.
Arch. Biochem. Biophys.
315:
1-7,
1994[Medline].
6.
Gratama, J. W. C.,
J. J. Meuzelaar,
M. Dalinghaus,
J. H. Koers,
A. M. Gerding,
M. T. M. Monchen,
F. C. Tenijenhuis,
W. G. Zijlstra,
and
J. G. Kuipers.
Myocardial blood flow and
O2 in lambs with an aortopulmonary shunt during strenous exercise.
Am. J. Physiol.
264 (Heart Circ. Physiol. 33):
H938-H945,
1993[Abstract/Free Full Text].
7.
Hale, D. E.,
and
J. R. Williamson.
Developmental changes in the adenine nucleotide translocase in the guinea pig.
J. Biol. Chem.
259:
8737-8742,
1984[Abstract/Free Full Text].
8.
Harris, D. A.,
and
A. M. Das.
Control of mitochondrial ATP synthesis in the heart.
Biochem. J.
280:
561-573,
1991.
9.
Heineman, F. W.,
and
R. S. Balaban.
Control of mitochondrial respiration in the heart in vivo.
Annu. Rev. Physiol.
52:
523-542,
1990[Medline].
10.
Holness, M.,
A.-A. Crespo,
and
J. Mowbray.
The influence of thyroid hormone on the degree of control of oxidative phosphorylation exerted by the adenine nucleotide translocator.
FEBS Lett.
177:
231-235,
1984[Medline].
11.
Hoppner, W.,
U. B. Rasmussen,
G. Abuerreish,
H. Wohlrab,
and
H. J. Seitz.
Thyroid hormone effect on gene expression of the adenine nucleotide translocase in different rat tissues.
Mol. Endocrinol.
2:
1127-1131,
1988[Abstract/Free Full Text].
12.
Ingwall, J. S.,
M. F. Kramer,
D. Woodman,
and
W. F. Friedman.
Maturation of energy metabolism in the lamb: changes in myosin ATPase and creatine kinase activities.
Pediatr. Res.
15:
1128-1133,
1981[Medline].
13.
Izquierdo, J. M.,
and
J. M. Cuezva.
Evidence of post-transcriptional regulation in mammalian mitochondrial biogenesis.
Biochem. Biophys. Res. Commun.
196:
55-60,
1993[Medline].
14.
Izquierdo, J. M.,
J. Ricart,
L. K. Ostronoff,
G. Egea,
and
J. M. Cuezva.
Changing patterns of transcriptional and post-transcriptional control of
1-F1-ATPase gene expression during mitochondrial biogenesis in liver.
J. Biol. Chem.
263:
7767-7775,
1995[Abstract/Free Full Text].
15.
Jacobus, W. E.,
R. W. Moreadith,
and
K. M. Vandegaer.
Mitochondrial respiratory control.
J. Biol. Chem.
257:
2397-2402,
1982[Abstract/Free Full Text].
16.
Jacobus, W. E.,
R. W. Moreadith,
and
K. M. Vandegaer.
Mitochondrial respiratory control. Evidence against the regulation of respiration by extramitochondrial phosphorylation potentials or by [ATP]/[ADP] ratios.
J. Biol. Chem.
257:
2397-2402,
1982.
17.
Jeneson, J. A. L.,
R. W. Wiseman,
H. V. Westerhoff,
and
M. J. Kushmerick.
The signal transduction function for oxidative phosphorylation is at least second order in ADP.
J. Biol. Chem.
271:
27995-27998,
1996[Abstract/Free Full Text].
18.
Katz, L. A.,
J. A. Swain,
M. A. Portman,
and
R. S. Balaban.
Relation between phosphate metabolites and oxygen consumption of heart in vivo.
Am. J. Physiol.
256 (Heart Circ. Physiol. 25):
H265-H274,
1989[Abstract/Free Full Text].
19.
Koshland, D. E.
Amplification and adaptation in regulatory and sensory systems.
Science
217:
220-225,
1982[Free Full Text].
20.
LaNoue, K. F.,
F. M. H. Jeffries,
and
G. K. Radda.
Kinetic control of mitochondrial ATP synthesis.
Biochemistry
25:
767-775,
1986[Medline].
21.
Lawson, J. W.,
and
R. L. Veech.
Effects of pH and free Mg++ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions.
J. Biol. Chem.
254:
6528-6537,
1979[Abstract/Free Full Text].
22.
Luis, A. M.,
J. M. Izquierdo,
L. Ostronoff,
M. Salina,
F. Santaren,
and
J. M. Cuezva.
Translational regulation of mitochondrial differentiation in neonatal rat liver.
J. Biol. Chem.
262:
7767-7775,
1993.
23.
Portman, M. A.
Myocardial energy metabolism in the newborn lamb in vivo during pacing induced changes in oxygen consumption.
Pediatr. Res.
37:
1-7,
1995[Medline].
24.
Portman, M. A.,
F. W. Heineman,
and
R. S. Balaban.
Developmental changes in the relation between phosphate metabolites and oxygen consumption in the sheep heart in vivo.
J. Clin. Invest.
83:
456-464,
1989.
25.
Portman, M. A.,
and
X.-H. Ning.
Maturational changes in respiratory control through creatine kinase in heart in vivo.
Am. J. Physiol.
263 (Cell Physiol. 32):
C453-C460,
1992[Abstract/Free Full Text].
26.
Portman, M. A.,
T. A. Standaert,
and
X.-H. Ning.
Developmental changes in ATP utilization during hypoxia and reoxygenation in the heart in vivo.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H216-H223,
1996[Abstract/Free Full Text].
27.
Rodwell, V. W.
Enzymes: kinetics.
In: Harper's Biochemistry (24th ed.), edited by R. K. Murray. Stamford, CT: Appleton & Lang, 1996, p. 75-90.
28.
Schonfeld, P.
Expression of the ADP/ATP carrier and expansion of the mitochondrial (ATP + ADP) pool contribute to postnatal maturation of the rat heart.
Eur. J. Biochem.
241:
895-900,
1996[Medline].
29.
Schonfeld, P.,
S. Fritz,
W. Halangk,
and
R. Bohensack.
Increase in the adenine nucleotide translocase protein contributes to perinatal maturation of respiration in rat liver mitochondria.
Biochim. Biophys. Acta
1144:
353-358,
1993[Medline].
30.
Stepien, G.,
A. Torroni,
A. B. Chung,
J. A. Hodge,
and
D. C. Wallace.
Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation.
J. Biol. Chem.
267:
14592-14597,
1992[Abstract/Free Full Text].
31.
Sterling, K.
Direct thyroid hormone activation of mitochondria: the role of adenine nucleotide translocase.
Endocrinology
119:
292-295,
1986[Abstract/Free Full Text].
32.
Wells, R. J.,
W. F. Friedman,
and
B. E. Sobel.
Increased oxidative metabolism in the fetal and newborn lamb heart in vivo.
Am. J. Physiol.
226:
1488-1493,
1972.
AJP Heart Circ Physiol 273(4):H1977-H1983
0363-6135/97 $5.00
Copyright © 1997 the American Physiological Society